Last $296.74 USD
Change Today -3.40 / -1.13%
Volume 607.2K
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Leonard S. Schleifer M.D., Ph.D.

Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee, Regeneron Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 116 board members in 2 different organizations across 1 different industries.

See Board Relationships
60$30,047,097
As of Fiscal Year 2012

Background*

Dr. Leonard S. Schleifer, M.D., Ph.D. Founded Regeneron Pharmaceuticals, Inc. in 1988 and has been its President and Chief Executive Officer since 1988. Dr. Schleifer served as the Chairman of Regeneron Pharmaceuticals from 1990 to 1994. In 1992, Dr. Schleifer was appointed Clinical Professor of Neurology at the Cornell University Medical School, and from 1984 to 1988 he served as an Assistant Professor of the Cornell University Medical School in the Departments of Neurology ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-347-7000
Fax: --

Board Members Memberships*

Director
1988-Present
Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee

Education*

PhD
University of Virginia
MD
University of Virginia

Other Affiliations*

Annual Compensation*

Salary$1,000,000
Bonus$2,300,000
Total Annual Compensation$3,300,000

Stock Options*

All Other Compensation$116,791
Exercised Options543,757
Exercised Options Value$49,125,902
Exercisable Options1,693,915
Exercisable Options Value$255,763,461
Unexercisable Options922,500
Unexercisable Options Value$82,646,275
Total Value of Options$387,535,638
Total Number of Options3,160,172

Total Compensation*

Total Annual Cash Compensation$3,416,791
Total Short Term Compensation$3,300,000
Other Long Term Compensation$116,791
Total Calculated Compensation$30,047,097
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REGN:US $296.74 USD -3.40

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$821.1K
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
$1.4M
Leonard Bell M.D.Co-Founder, Chief Executive Officer, Treasurer and Director
Alexion Pharmaceuticals, Inc.
$1.1M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$722.2K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.